Suppr超能文献

相似文献

2
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1989-1998. doi: 10.2215/CJN.02110216. Epub 2016 Aug 25.
3
Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.
Clin J Am Soc Nephrol. 2011 Nov;6(11):2688-95. doi: 10.2215/CJN.04290511. Epub 2011 Sep 8.
4
Serum FGF23 levels in normal and disordered phosphorus homeostasis.
J Bone Miner Res. 2003 Jul;18(7):1227-34. doi: 10.1359/jbmr.2003.18.7.1227.
5
Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.
Heart Vessels. 2021 Mar;36(3):414-423. doi: 10.1007/s00380-020-01704-y. Epub 2020 Sep 30.
6
Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy.
Endocr Res. 2017 May;42(2):132-137. doi: 10.1080/07435800.2016.1242604. Epub 2016 Oct 18.
7
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.
Curr Opin Nephrol Hypertens. 2014 Jul;23(4):411-9. doi: 10.1097/01.mnh.0000447020.74593.6f.
8
Serum fibroblast growth factor 23 concentration and the risk of mortality in patients undergoing peritoneal dialysis.
Perit Dial Int. 2024 May;44(3):194-202. doi: 10.1177/08968608241231697. Epub 2024 Mar 6.
10
Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.
Am J Nephrol. 2019;49(4):263-270. doi: 10.1159/000497445. Epub 2019 Feb 28.

引用本文的文献

1
X-Linked Hypophosphatemia: Role of Fibroblast Growth Factor 23 on Human Skeletal Muscle-Derived Cells.
Calcif Tissue Int. 2025 Sep 9;116(1):120. doi: 10.1007/s00223-025-01415-4.
2
FGFR4 Is Required for Concentric Growth of Cardiac Myocytes during Physiologic Cardiac Hypertrophy.
J Cardiovasc Dev Dis. 2024 Oct 12;11(10):320. doi: 10.3390/jcdd11100320.
5
Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients.
Clin Kidney J. 2023 Mar 10;16(10):1622-1633. doi: 10.1093/ckj/sfad040. eCollection 2023 Oct.
6
1,25-Dihydroxyvitamin D3 regulates furin-mediated FGF23 cleavage.
JCI Insight. 2023 Sep 8;8(17):e168957. doi: 10.1172/jci.insight.168957.
7
The rationale for intermittent administration of PTH in the management of mineral and bone disorder of chronic kidney disease.
J Nephrol. 2024 Mar;37(2):337-342. doi: 10.1007/s40620-023-01642-8. Epub 2023 May 12.
8
High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis.
Front Med (Lausanne). 2023 Apr 4;10:1098871. doi: 10.3389/fmed.2023.1098871. eCollection 2023.
9
Relationship between serum iPTH and peritonitis episodes in patients undergoing continuous ambulatory peritoneal dialysis.
Front Endocrinol (Lausanne). 2023 Mar 27;14:1081543. doi: 10.3389/fendo.2023.1081543. eCollection 2023.
10
Mineral Metabolism in Children: Interrelation between Vitamin D and FGF23.
Int J Mol Sci. 2023 Apr 3;24(7):6661. doi: 10.3390/ijms24076661.

本文引用的文献

1
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.
Circulation. 2009 May 19;119(19):2545-52. doi: 10.1161/CIRCULATIONAHA.108.844506. Epub 2009 May 4.
2
High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
Nephrol Dial Transplant. 2009 Sep;24(9):2792-6. doi: 10.1093/ndt/gfp191. Epub 2009 Apr 25.
3
Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients.
Am J Med Sci. 2009 Feb;337(2):116-22. doi: 10.1097/MAJ.0b013e3181815498.
4
Phosphorus binders and survival on hemodialysis.
J Am Soc Nephrol. 2009 Feb;20(2):388-96. doi: 10.1681/ASN.2008060609. Epub 2008 Dec 17.
5
Type IIc sodium-dependent phosphate transporter regulates calcium metabolism.
J Am Soc Nephrol. 2009 Jan;20(1):104-13. doi: 10.1681/ASN.2008020177. Epub 2008 Dec 3.
7
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.
N Engl J Med. 2008 Aug 7;359(6):584-92. doi: 10.1056/NEJMoa0706130.
8
Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23.
J Bone Miner Res. 2008 Sep;23(9):1509-18. doi: 10.1359/jbmr.080417.
9
Public health approach to addressing hyperphosphatemia among dialysis patients.
J Ren Nutr. 2008 May;18(3):256-61. doi: 10.1053/j.jrn.2007.12.002.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验